No Data
Jinyao Pharmaceutical: Summary of the 2024 Annual Report of Jinyao Pharmaceutical Co., Ltd.
Jinyao Pharmaceutical: 2024 Annual Report of Jinyao Pharmaceutical Co., Ltd.
2024 Annual Report of Tianjin Pharmaceutical Co., Ltd.
Summary of the 2024 Annual Report of Tianjin Pharmaceutical Co., Ltd.
Tianjin Tianyao Pharmaceuticals (600488.SH): In 2024, net income is expected to grow by 14.01% year-on-year, proposing a dividend of 0.98 yuan per 10 shares.
Gelonghui March 26 announcement | Tianjin Tianyao Pharmaceuticals (600488.SH) announced the 2024 annual report, in which the company achieved revenue of 3.215 billion yuan, a decrease of 15.00% year-on-year, net income attributable to shareholders of the listed company was 0.133 billion yuan, an increase of 14.01%, and export revenue reached 0.145 billion dollars. A cash dividend of 0.98 yuan is distributed for every 10 shares to all shareholders.
Jinyao Pharmaceuticals Obtains Drug Registration for Opioid Overdose Drug
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)
